DALLAS, May 6, 2020 — Recent reports of children experiencing Kawasaki disease, possibly tied to the COVID-19 pandemic, are raising concerns among patients and pediatricians.
Most children with COVID-19 are asymptomatic or exhibit only mild symptoms. However, in the past two months, first in Europe, and more recently in the U.S., a small number of children developed a more serious inflammatory syndrome with COVID-19, often leading to hospitalization and occasionally requiring intensive care.
COVID-19 infection leading to critical illness in children remains very infrequent. According to the leaders of the American Heart Association’s Council on Lifelong Congenital Heart Disease and Heart Health in the Young (Young Hearts), a few patients display symptoms found in other pediatric inflammatory conditions, most notably Kawasaki disease. Kawasaki disease is a rare condition that presents with a fever above 102°F to 104°F for at least five days, swelling of the lymph nodes, inflammation, a rash and other symptoms.
Children with this new, possibly COVID-19-related syndrome may have some or all the features of Kawasaki disease. These children have a persistent fever, inflammation and evidence of single or multi-organ dysfunction (shock, cardiac, respiratory, renal, gastrointestinal or neurological disorder) and may or may not test positive for COVID-19.
“We want to reassure parents – this appears to be uncommon. While Kawasaki disease can damage the heart or blood vessels, the heart problems usually go away in five or six weeks, and most children fully recover,” said Jane Newburger, M.D., M.P.H., FAHA, American Heart Association Young Hearts Council member, associate cardiologist-in-chief, academic affairs; medical director of the neurodevelopmental program; and director of the Kawasaki Program at Boston Children’s Hospital; and Commonwealth Professor of Pediatrics at Harvard Medical School. “Rarely, but sometimes, the coronary artery damage persists. Because of this, Kawasaki disease is the most common cause of acquired heart disease in children in developed countries. Prompt treatment is critical to prevent significant heart problems.”
Since some children are becoming very ill extremely quickly, children with these symptoms should be swiftly evaluated and cared for in hospitals with pediatric cardiac intensive care units, as needed. Because there is a small but increasing number of children with fever and evidence of inflammation who are not severely ill, all children with unexplained fever and elevated C- Reactive Protein (CRP) or white blood cell count should be carefully monitored.
In order to learn more, the American Heart Association’s Young Hearts Council feels it is important for children to be enrolled, wherever possible, in COVID-19 research projects that include obtaining serum or plasma samples, DNA and RNA studies for biobanking. Clinical trials and data integration across existing and planned registries of children ill from COVID-19 are needed. The Council is adopting the case definition put forth by the Royal College of Paediatrics and Child Health..
Further research is needed on the full spectrum of inflammatory disorders that appear to be related to COVID-19. Recently, the American Heart Association funded 12 research grants looking at the heart and brain health implications of coronavirus including a study examining impacts on the cardiovascular system due to a robust inflammatory response.
The American Heart Association’s Young Hearts Council is a volunteer scientific group of leading pediatric cardiologists.
- AHA’s COVID-19 Professional Resources
- Answers By Heart: What is Kawasaki Disease?
- Kawasaki Disease: Signs and Symptoms
- Follow AHA/ASA news on Twitter @HeartNews
About the American Heart Association
The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.
For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173
Michelle Kirkwood: email@example.com; 703-457-7838
Public Inquiries: 1-800-AHA-USA1 (242-8721)